This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A whitepaper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month.
The American College of Emergency Physicians recently withdrew a 2009 whitepaper endorsing the concept, and California has banned it as a cause of death. It came up most recently in the trials of two police officers accused of causing the death of Elijah McClain, a Colorado man; both officers were acquitted this week.
In a bid to answer some of these questions for industry, healthcare intelligence provider Wilmington Healthcare has published a whitepaper, entitled “Covid-19: Roadmap to Recovery”. To register to download the free whitepaper visit [link]. The challenge now is to maintain and strengthen partnership working.
Explore the key moments of truth in launch excellence for MSLs and commercial teams in this informative whitepaper. Gain valuable insights and strategies for successful launches.
This whitepaper provides valuable insights into the successful application of enteric polymer coatings for controlled drug delivery systems. By selecting enteric coatings, formulators can ensure the protection of their acid-sensitive APIs and create a controlled release drug delivery system.
The Transformational Value: Preparing for a Decade of Radical Change whitepaper from the Adelphi Group sets out the key tenets of the concept and the opportunity for pharma to take a big picture view of ‘transformational value’ and how to respond to it. The post Preparing for a decade of radical change in pharma appeared first on.
A Vizient whitepaper demonstrates how the lack of information about medication access across the supply chain is exacerbating the shortage of seven oncology drugs used to treat a multitude of cancers.
Learn how to effectively deal with fragmented data by leveraging Veeva Open Data in this informative whitepaper. Gain insights on how to streamline data management processes and improve data quality.
Name * First Last Email * Company Please tell us here if you have any other questions, and we'll be in touch shortly Submit The post Download WhitePaper: Maximizing Shared Savings for Payviders: ACOs, IDNs, At-Risk Provider Groups and Clinics appeared first on PharmD Live.
The new whitepaper launched today by our publisher Cogora has laid bare the scale of the workforce crisis across general practice and explores where pharmacists sit within this. GP practices across England are struggling to recruit pharmacists because of local competition and issues related to pay, an exclusive report has suggested.
Havas Lynx Group’s 2020 whitepaper provides a blueprint for pharma brands to inject meaning into their media. The latter is the subject of our 2020 whitepaper, Media Means Business. Download the Media Means Business whitepaper today at [link]. What do we mean by ‘media’? About the author.
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a policy paper on its strategic approach to artificial intelligence (AI). It summarises the MHRA’s view on the UK government’s whitepaper on AI regulation published in 2023.
In The Medscape Professional Networks’ latest whitepaper, Healthcare’s New Normal: COVID Speeds Shift to Digital Communications , key opinion leaders and industry experts agree that in the post-pandemic world, even as lockdowns are lifted and restrictions relaxed, the emerging trends for an increase in digital communications will stay.
The key trends for these sectors are identified and analysed in a new whitepaper from Healthware Group that offers guidance on how companies can best adjust to the new digital scenario. In the whitepaper, expert contributors share a detailed picture of the digital trends with the greatest potential to impact the near future.
A new whitepaper from 60 Seconds, Genuine Transformation: Preparing for Pharma’s New Sales Coaching Reality , looks at the recent evolution of the pharma sales function and discusses how training and coaching changed during the pandemic and how to prepare for what is coming next. This whitepaper explains how to adjust to it.
Explore the latest digital health innovation applications across the patient journey, with this whitepaper by Healthinkers and EVERSANA INTOUCH. Stay informed and discover the future of healthcare technology.
The whitepaper Transform patient experience with intelligent hyper-personalisation examines some of the key ways in which pharma companies can transform patient experience by identifying, meeting and exceeding expectations.
The new Cancer Care in Europe: Recovering from COVID-19 Disruption whitepaper assesses the disruption to patient care and the changes physicians implemented during the acute phase of the pandemic, with a focus on the way in which treatment strategies were altered.
This whitepaper provides valuable information for professionals in the field. Explore the latest trends and insights in the life sciences industry with Part 7 of our industry report.
This whitepaper provides in-depth analysis and key findings for industry professionals. Discover valuable insights into the rare disease landscape in Part 6 of our Life Sciences Industry Report.
Malaysia: Health WhitePaper The Health WhitePaper , which was first tabled in the Parliament on 14 June 2023, is a comprehensive proposal to revamp the country's healthcare system for a higher quality, more sustainable and resilient health system in stages over a 15-year period.
Discover the evolving landscape of journal performance measurement with this informative whitepaper. Learn how metrics and evaluation methods are changing in the scholarly publishing industry.
Explore the latest update on the World Without Disease initiative in 2024 with our comprehensive whitepaper. Discover the progress, challenges, and future prospects of this groundbreaking global health initiative.
Explore the latest update on the World Without Disease initiative in 2024 with our comprehensive whitepaper. Discover the progress, challenges, and future prospects of this groundbreaking global health initiative.
The deal comes shortly after the publication of a whitepaper that laid out a framework that could be adopted by Italy to realise the potential of DTx, including the creation of a reimbursement pathway similar to that set up in Germany. .
In this whitepaper Pfizer CentreOne examines what developers and their manufacturing partners need to know about its unique regulatory challenges and how to navigate HPOSD’s complex manufacturing environment successfully.
In this whitepaper, Pfizer CentreOne discusses how a small or medium sized biotech or pharma company can benefit from the experience and assistance provided by a CDMO.
In this whitepaper, learn how a SaaS-based LIMS modernization program optimizes data management, fosters collaboration, and improves decision-making to stay at the forefront of scientific innovation. As today’s labs continue to evolve, the software solutions that support them must too.
By downloading this Whitepaper, you acknowledge that we may share your information with our whitepaper partners/sponsors who may contact you directly with information on their products and services.
This whitepaper from Jubilant HollisterStier discusses the range of factors to consider when outsourcing manufacturing for aseptically filled and terminally sterilized products. Vetting a CMO for sterile injectable fill finish means more than capacity and equipment.
In this whitepaper, learn how a platform approach to scientific data management, including semantic search, advanced analytics, and lab automation, leads to better enterprise decisions at the executive level, optimized lab performance, more discoveries, and stronger product pipelines.
This GEP-Procurement Leaders whitepaper — Embedded AI: The Catalyst for Technological Change — outlines how procurement professionals are using AI-driven data preparation and analysis tools to achieve better outcomes. But that requires a ton of IT resources. Or does it?
This whitepaper details how manufacturing leaders can leverage advanced analytics to improve product quality and yield, reduce errors and rework, and drive higher operating margins. It showcases that SAS advanced analytics can help solve quality issues by integrating disparate data and optimising processes.
This whitepaper discusses the role of project management at Jubilant HollisterStier in creating and executing transfer plans and the innovative solutions developed for the transfer of five COVID-19 vaccine and therapeutic fill finish manufacturing projects. Central to a successful technology transfer is effective project management.
By downloading this Whitepaper, you acknowledge that we may share your information with our whitepaper partners/sponsors who may contact you directly with information on their products and services.
In this paper, learn about a variety of genetic analysis methods and how they’re valuable in ensuring that ex vivo human cells used for cell?based Download the whitepaper and read more about the importance of quality control (QC) for isolated human cells and tissues.
This whitepaper presents an overview of mixing technologies implemented across many of today’s highly competitive pharmaceutical and medical industries, as well as new equipment designs that are increasingly being recognized as potential solutions to prevailing mixing challenges.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content